Controversies in Systemic Lupus Erythematosus Are We Treating Our Patients Adequately? (2022)
Source: Jcr-journal of clinical rheumatology. Unidade: FM
Subjects: SUBSTÂNCIAS TÓXICAS, LÚPUS ERITEMATOSO SISTÊMICO, NEFRITE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PORTA, Sabrina Valeria et al. Controversies in Systemic Lupus Erythematosus Are We Treating Our Patients Adequately?. Jcr-journal of clinical rheumatology, v. 28, n. 2, p. E651-E658, 2022Tradução . . Disponível em: https://doi.org/10.1097/RHU.0000000000001803. Acesso em: 17 ago. 2024.APA
Porta, S. V., Ugarte-Gil, M. F., Torre, I. G. -de la, Bonfa, E. S. D. de O., Gomez-Puerta, J. A., Arnaud, L., et al. (2022). Controversies in Systemic Lupus Erythematosus Are We Treating Our Patients Adequately? Jcr-journal of clinical rheumatology, 28( 2), E651-E658. doi:10.1097/RHU.0000000000001803NLM
Porta SV, Ugarte-Gil MF, Torre IG-de la, Bonfa ESD de O, Gomez-Puerta JA, Arnaud L, Cardiel MH, Alarcon GS, Pons-Estel BA, Pons-Estel G. Controversies in Systemic Lupus Erythematosus Are We Treating Our Patients Adequately? [Internet]. Jcr-journal of clinical rheumatology. 2022 ; 28( 2): E651-E658.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1097/RHU.0000000000001803Vancouver
Porta SV, Ugarte-Gil MF, Torre IG-de la, Bonfa ESD de O, Gomez-Puerta JA, Arnaud L, Cardiel MH, Alarcon GS, Pons-Estel BA, Pons-Estel G. Controversies in Systemic Lupus Erythematosus Are We Treating Our Patients Adequately? [Internet]. Jcr-journal of clinical rheumatology. 2022 ; 28( 2): E651-E658.[citado 2024 ago. 17 ] Available from: https://doi.org/10.1097/RHU.0000000000001803